- Report
- August 2025
- 488 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 575 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 401 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 294 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 255 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 217 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 375 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 381 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 162 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- August 2025
- 309 Pages
Global
From €5174EUR$5,850USD£4,467GBP
- Report
- March 2025
- 184 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- March 2025
- 182 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- February 2025
- 185 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- January 2025
- 183 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- September 2024
- 183 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- August 2024
- 180 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- July 2025
- 180 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- May 2025
- 185 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- February 2025
- 183 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- January 2025
- 180 Pages
Global
From €3980EUR$4,500USD£3,436GBP

The Cancer Research market is a subset of the Drug Discovery market, focused on the development of treatments for cancer. This market is composed of a variety of stakeholders, including pharmaceutical companies, research institutions, and government agencies. These stakeholders collaborate to develop new treatments and therapies for cancer, as well as to improve existing treatments. The market is driven by the need to find new and effective treatments for cancer, as well as to improve the quality of life for those affected by the disease.
The Cancer Research market is highly competitive, with many companies vying for a share of the market. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. These companies are engaged in research and development of new treatments and therapies for cancer, as well as the marketing and distribution of existing treatments. Show Less Read more